Skip to main content
SpringerLink
Log in

Hyperlipoproteinämien

  • Chapter
  • First Online:
Pädiatrie

  • 470 Accesses

Zusammenfassung

Hyperlipidämien (Synonym: Hyperlipoproteinämien) sind biochemische Veränderungen, bei denen ein oder mehrere Anteile der Serumlipide (Cholesterin, Triglyceride oder beide) und eines oder mehrere der diese Lipide transportierenden Lipoproteine vermehrt sind. Bei den meisten sind multiple genetische und/oder exogene Faktoren kausal beteiligt; bei manchen wird die Hyperlipoproteinämie durch einen ganz bestimmten Gendefekt, der den Lipidmetabolismus beeinflussen kann, verursacht. Epidemiologische Studien haben den Beweis erbracht, dass ein direkter Zusammenhang zwischen der Serumcholesterinkonzentration und der Häufigkeit des Auftretens von atherosklerotischen Gefäßveränderungen besteht.

Atherosklerose stellt nach wie vor die weitaus überwiegende Ursache der Koronargefäßerkrankung dar. Etwa die Hälfte der Todesfälle in Europa wird mittelbar oder unmittelbar durch diese Krankheit verursacht.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 249.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Umrechnung: mg/dl × 0,01 = g/l.

Literatur

  • American Academy of Pedatrics Committee on Nutrition (1998) Cholesterol in childhood. Pediatrics 101:141–147

    Google Scholar 

  • Berenson GS, Srinivasan SR, Bao W et al (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 338:1650–1656

    Article  CAS  PubMed  Google Scholar 

  • Clarke WR, Schrott HG, Leaverton PE et al (1978) Tracking of blood lipids and blood pressures in school age children: the Muscatine study. Circulation 58:626–663

    Article  CAS  PubMed  Google Scholar 

  • Clauss SB, Kwiterovich PO (2003) Genetic disorders of lipoprotein transport in children. Prog Pediatr Cardiol 17:123–133

    Article  Google Scholar 

  • Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents (2011) Summary report. Pediatrics 128:S213

    Article  Google Scholar 

  • Goldstein JL, Brown MS (1973) Familial hypercholesterolemia: Identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A-reductase activity associated with overproduction of cholesterol. Proc Natl Acad Sci U S A 70:2804–2808

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Havel RJ, Kane JP (2001) Introduction: Structure and metabolism of plasma lipoproteins. In: Scriver CR, Beaudet AL, Sly WS, Valle D (Hrsg) The metabolic and molecular bases of inherited disease, 8. Aufl. McGraw Hill, New York, S 2705–2716

    Google Scholar 

  • Heath KE, Gudnason V, Humphries SE, Seed M (1999) The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia. Atherosclerosis 143:41–54

    Article  CAS  PubMed  Google Scholar 

  • Karvey RE, Daniels SR, Lauer RM et al (2003) American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in chilhood. Circulation 107:1562–1566

    Article  Google Scholar 

  • Klag MJ, Ford DE, Mead LA et al (1993) Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 328:313–318

    Article  CAS  PubMed  Google Scholar 

  • Koeijvoets KC, Wiegman A, Rodenburg J et al (2005) Effect of low-density lipoprotein receptor mutation on lipoproteins and cardiovascular disease risk: A parent-offspring study. Atherosclerosis 180:93–99

    Article  CAS  PubMed  Google Scholar 

  • Kusters DM, de Beaufort C, Widhalm K, Guardamagna D, Ose L, Wiegman A (2012) Pediatric screening for hypercholesterolemia in Europe. Arch Dis Child 97:272–276

    Article  CAS  PubMed  Google Scholar 

  • McGill HC Jr, McMahan CA, Malcolm GT et al (1997) Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological determinants of athero-sclerosis in youth. Arterioscler Thromb Vasc Biol 17:95–106

    Article  PubMed  Google Scholar 

  • Müller C (1938) Xanthomata, hypercholesterolemia, angina pectoris. Acta Med Scand 89:75

    Google Scholar 

  • Newman WP, Freedman DS, Voos AW et al (1986) Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa heart study. N Engl J Med 314:138–144

    Article  PubMed  Google Scholar 

  • Stein EA, Illingworth DR, Kwiterovich PO et al (1999) Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA 281:137–144

    Article  CAS  PubMed  Google Scholar 

  • Strong JP, Malcolm GT, McMahan CA et al (1999) Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 281:727–735

    Article  CAS  PubMed  Google Scholar 

  • Widhalm K, Brazda G, Schneider B et al (1993) Effect of soy protein diet versus standard low fat, low cholesterol diet on lipid and lipoprotein levels in children with familial of polygenic hypercholesterolemia. J Pediatr 123:30–34

    Article  CAS  PubMed  Google Scholar 

  • Wiegman A, Rodenburg J, de Jongh S et al (2003) Family history and cardio-vascular risk in familal hypercholesterolemia. Data in more than 1000 children. Circulation 107:1473–1478

    Article  PubMed  Google Scholar 

  • Williams CL, Hayman LL, Daniels SR et al (2002) Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 106:143–160

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ernährungsmedizin, Österreichisches Akademisches Institut für, Alserstr. 14/4a, 1090, Wien, Österreich

    Kurt Widhalm Prof. em. Dr. med.

Authors
  1. Kurt Widhalm Prof. em. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentrum für Kinder und Jugendmedizin, Universitätsklinikum Heidelberg, Heidelberg, Germany

    Georg F. Hoffmann

  2. Forschungsinstitut für Kinderernährung, Dortmund, Germany

    Michael J. Lentze

  3. Zentrum für Kinder- und Jugendmedizin, Universitätsmedizin Mainz, Mainz, Germany

    Jürgen Spranger

  4. Zentrum für Kinder- und Jugendmedizin, Universitätsmedizin Mainz, Mainz, Germany

    Fred Zepp

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Widhalm, K. (2014). Hyperlipoproteinämien. In: Hoffmann, G., Lentze, M., Spranger, J., Zepp, F. (eds) Pädiatrie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41866-2_55

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-41866-2_55

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-41865-5

  • Online ISBN: 978-3-642-41866-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation